Dose-dependent Pharmacokinetics of Alpha-methyl-p-tyrosine (alpha-MT) and Comparison of Catecholamine Turnover Rates After Two Doses of Alpha-MT

Overview

Journal J Neural Transm

Specialties Neurology
Physiology

Date 1979 Jan 1

PMID 438807

Citations 6

Authors

E Widerlov

Affiliations

Soon will be listed here.

Abstract

Groups of rats were injected i.p. with 0.407 or 1.02 mmoles/kg of D,L-alpha-methyl-p-tyrosine methylester HCl (alpha-MT). The time-courses for alpha-MT in plasma and brain were followed together with the endogenous brain dopamine (DA) and noradrenaline (NA) contents. The elimination of alpha-MT from plasma and brain was markedly delayed after the high alpha-MT dose compared with the low dose. At 40 hours after the injection of 1.02 mmoles/kg of alpha-MT both plasma and brain levels were high, whereas no alpha-MT could be detected in plasma or brain at 16 hours after the lower dose. The brain catecholamines were decreased to very low values after the higher alpha-MT dose (DA 14% and NA 10% of controls at 8 and 24 hours respectively). There was no complete recuperation at 40 hours of any of the amines. After the lower alpha-MT dose, the DA concentration was back to control levels at 16 hours and NA at 12 hours. Between 16--40 hours after the high alpha-MT dose a majority of the rats showed prominent signs of sedation, weight loss and dehydration. No such signs were observed in rats receiving 0.407 mmoles/kg. During the first hour after the alpha-MT injection the declines of DA and NA respectively were almost identical for both alpha-MT doses. When the whole time-course (0--8 hours) after the high dose was considered, biphasic declines were obtained for both DA and NA, suggesting at least two different catecholamine pools. However, due to toxic effects after the high alpha-MT dose, turnover data have to be interpreted with caution.

Citing Articles

Alteration of Postural Reactions in Rats with Different Levels of Dopamine Depletion.

Kalinina D, Lyakhovetskii V, Gorskii O, Shkorbatova P, Pavlova N, Bazhenova E Biomedicines. 2023; 11(7).

PMID: 37509596 PMC: 10377029. DOI: 10.3390/biomedicines11071958.

L-DOPA Improves Ventilation but Not the Ventilatory Response to Hypercapnia in a Reserpine Model of Parkinson's Disease.

Jampolska M, Andrzejewski K, Boguszewski P, Kaczynska K Brain Sci. 2023; 13(5).

PMID: 37239247 PMC: 10216042. DOI: 10.3390/brainsci13050775.

Short-latency activation of striatal spiny neurons via subcortical visual pathways.

Schulz J, Redgrave P, Mehring C, Aertsen A, Clements K, Wickens J J Neurosci. 2009; 29(19):6336-47.

PMID: 19439610 PMC: 3128488. DOI: 10.1523/JNEUROSCI.4815-08.2009.

Role of neuronal nitric oxide in the regulation of vasopressin expression and release in response to inhibition of catecholamine synthesis and dehydration.

Yamova L, Atochin D, Glazova M, Chernigovskaya E, Huang P Neurosci Lett. 2007; 426(3):160-5.

PMID: 17904738 PMC: 2768346. DOI: 10.1016/j.neulet.2007.08.066.

Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function.

WOLKIN A, Duncan E, Sanfilipo M, Wieland S, Cooper T, Rotrosen J J Neural Transm Gen Sect. 1994; 95(1):49-61.

PMID: 7857586 DOI: 10.1007/BF01283030.

References

Spector S . Inhibitors of endogenous catecholamine biosynthesis. Pharmacol Rev. 1966; 18(1):599-609. View

Moore K, Wright P, Bert J . Toxicologic studies with alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase. J Pharmacol Exp Ther. 1967; 155(3):506-15. View

Bunney B, Aghajanian G, Roth R . Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat New Biol. 1973; 245(143):123-5. DOI: 10.1038/newbio245123a0. View

Doteuchi M, Wang C, Costa E . Compartmentation of dopamine in rat striatum. Mol Pharmacol. 1974; 10(2):225-34. View

Costa E . Simple neuronal models to estimate turnover rate of noradrenergic transmitters in vivo. Adv Biochem Psychopharmacol. 1970; 2:169-204. View

Gudelsky G, Moore E . Differential drug effects on dopamine concentrations and rates of turnover in the median eminence, olfactory tubercle and corpus striatum. J Neural Transm. 1976; 38(2):95-105. DOI: 10.1007/BF01262968. View

Glowinski J, Iversen L . Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem. 1966; 13(8):655-69. DOI: 10.1111/j.1471-4159.1966.tb09873.x. View

Walinder J, Skott A, Carlsson A, ROOS B . Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. A long-term trial using double-blind crossover technique. Arch Gen Psychiatry. 1976; 33(4):501-5. DOI: 10.1001/archpsyc.1976.01770040061011. View

Widerlov E, Lewander T . The relationship between amphetamine antagonism and depletion of brain catecholamines by alpha-methyl-p-tyrosine in rats. Naunyn Schmiedebergs Arch Pharmacol. 1978; 304(2):125-34. DOI: 10.1007/BF00495548. View

10.

Magnusson G, CORRODI H, Hansson E . Renal lesions induced by alpha-methyltyrosine methylester and alpha-methyltyrosine. Acta Pharmacol Toxicol (Copenh). 1970; 28(6):435-44. DOI: 10.1111/j.1600-0773.1970.tb00569.x. View

11.

Sedvall G, Weise V, Kopin I . The rate of norepinephrine synthesis measured in vivo during short intervals; influence of adrenergic nerve impulse activity. J Pharmacol Exp Ther. 1968; 159(2):274-82. View

12.

Rech R, Borys H, Moore K . Alterations in behavior and brain catecholamine levels in rats treated with alpha-methyltyrosine. J Pharmacol Exp Ther. 1966; 153(3):412-9. View

13.

Engelman K, HORWITZ D, Jequier E, SJOERDSMA A . Biochemical and pharmacologic effects of alpha-methyltyrosine in man. J Clin Invest. 1968; 47(3):577-94. PMC: 297204. DOI: 10.1172/JCI105754. View

14.

Widerlov E, Lewander T . Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after alpha-methyl-p-tyrosine; time- and dose-response relationships. Naunyn Schmiedebergs Arch Pharmacol. 1978; 304(2):111-23. DOI: 10.1007/BF00495547. View

15.

JAVOY F, Glowinski J . Dynamic characteristic of the 'functional compartment' of dopamine in dopaminergic terminals of the rat striatum. J Neurochem. 1971; 18(7):1305-11. DOI: 10.1111/j.1471-4159.1971.tb00230.x. View

16.

Iversen L, Glowinski J . Regional studies of catecholamines in the rat brain. II. Rate of turnover of catecholamines in various brain regions. J Neurochem. 1966; 13(8):671-82. DOI: 10.1111/j.1471-4159.1966.tb09874.x. View

17.

UDENFRIEND S, ZALTZMAN-NIRENBERG P, Nagatsu T . Inhibitors of purified beef adrenal tyrosine hydroxylase. Biochem Pharmacol. 1965; 14(5):837-45. DOI: 10.1016/0006-2952(65)90103-6. View

18.

Moore K, Dominic J . Tyrosine hydroxylase inhibitors. Fed Proc. 1971; 30(3):859-70. View

19.

Nyback H . Regional disappearance of catecholamines formed from 14 C-tyrosine in rat brain: effect of synthesis inhibitors and of chlorpromazine. Acta Pharmacol Toxicol (Copenh). 1971; 30(5):372-84. DOI: 10.1111/j.1600-0773.1972.tb00669.x. View

20.

Brodie B, Costa E, Dlabac A, Neff N, SMOOKLER H . Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines. J Pharmacol Exp Ther. 1966; 154(3):493-8. View